Novo Holdings A/S, an investor in life science companies, has expanded its portfolio with the purchase on 15 June of a majority stake in BBI Group, a supplier of products and services to the global life science and diagnostics industries. The deal is valued at more than £400 million. Novo is buying the company from Exponent Private Equity LLP.
